Biotech in Austria: news and updates - Labiotech.eu

Home Austria Page 6

Latest Posts

brains imba cerebral organoids neurological disease

News and Trends 6 Jan 2016

Growing Mini-Brains in Labs to Better Understand Neurological Disease

Mini brains, about 3-4 mm are a breakthrough in Neurology which will enable researchers to study the development of neurological disease and perform drug tests ex vivo. Scientists from Institute of Molecular Biotechnology (IMBA) in Vienna are underpinning the secrets behind the most fascinating human’s organ, the brain. By essentially growing brains from scratch, the […]

January 6, 2016 - 2 minutesmins - By Joachim Eeckhout

morphosys multiple myeloma immunooncology mor202

News and Trends 7 Dec 2015

Best-in-Class Label for Blood Cancer Trial by Billion Euro Biotech

Latest results of MorphoSys candidate for Multiple Myeloma show that it was Celgene’s loss when it abandoned the phase I/IIa trial partnership on blood cancer. Announced at the American Society of Hematology (ASH) Annual Meeting this weekend in Orlando (US), the phase I/IIa drug for blood cancer from MorphoSys has shown good tolerability for this […]

December 7, 2015 - 3 minutesmins - By Dani Bancroft

vienna banner

News and Trends 13 Nov 2015

Biotech of the Week: Lexogen and it’s Transcriptomic Approach to Disease

This week we say ‘bye for noo’ to Edinburgh and head South East, across the English Channel and through both Netherlands and Germany where we arrive at this week’s destination, Vienna, Austria. This country is the place of birth of Mozart, has the only cuisine named after a city (Viennese) and absolutely stunning scenery, it is […]

November 13, 2015 - 2 minutesmins - By Philip Hemme

Sony DADC Blu Ray

News and Trends 6 Oct 2015

Sony DADC re-purposing Blu-Ray Technology for Clinical Immunoassays

Sony Digital Audio Disc Corporation (Sony DADC) BioSciences is a DVD and Blu-ray disc manufacturer headquartered in Salzburg (Austria). A new collaboration with FIONASTICS (an immunoassay specialist) means they will use their Blu-Ray tech to develop a new nanostructure platform for fluorescent immunoassays. These will be developed for use in detection of clinical biomarkers for […]

October 6, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 10 Aug 2015

Evotec enters Immuno-Oncology and Diabetes Therapy with Help from Sanofi

Evotec had to announce a setback recently when its Alzheimer’s treatment in collaboration with Roche failed in Phase IIb. However, another strong partner on its side, Sanofi, never lost trust in the German biotech’s value. In the last three days, the French giant entered into two new projects with Evotec, which target diabetes and immuno-oncology. […]

August 10, 2015 - 2 minutesmins - By Philip Hemme

grapefruit acib Nootkatone

News and Trends 15 Apr 2015

Synthetic bio: one single Grapefruit to produce one Million liters of Juice

The Austrian Centre of Industrial Biotechnology (acib), using synthetic biology technology, developed a new method to produce Nootkatone, an expensive grapefruit aroma. The biotechnological process uses cheap sugar as substrate for a “turbo-yeast”. The extremely expensive substance is used in soft drinks, pharmaceutical products or even as an insect repellent, and it is found only […]

April 15, 2015 - 2 minutesmins - By Lourdes Riquelme

ADVERTISEMENT

AOP Orphan Pharmaceuticals Confluence Pharmaceuticals Fragile X

News and Trends 23 Mar 2015

AOP Orphan and Confluence Pharmaceuticals, together for Fragile X Syndrome

AOP Orphan Pharmaceuticals and Confluence Pharmaceuticals, signed today a definitive agreement to co-develop and market Confluence’s lead asset, a product for the treatment of Fragile X Syndrome in Europe and the Middle East. Confluence is an American biopharmaceutical company focused on developing therapeutic treatments for Fragile X Syndrome and Autism Spectrum Disorders. The company has […]

March 23, 2015 - 2 minutesmins - By Lourdes Riquelme

VTU Technology1

News and Trends 10 Feb 2015

Is Pichia Pastoris the Best Protein Expression System?

Producing biologicals in living expression systems is a big challenge for the Biotech industry. World leaders in the field are betting on a new yield-enhancing expression technology using the yeast Pichia pastoris. Escherichia coli might be the first bacteria you think about when it comes to biotechnology. However, E. coli is not necessarily the best option to produce […]

February 10, 2015 - 4 minutesmins - By Lourdes Riquelme

colon cancer

News and Trends 26 Sep 2014

An Innovative Test to Detect Colon Cancer on Time

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three organizations will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers. The three structures will work closely together to develop the in-vitro diagnostic test […]

September 26, 2014 - 2 minutesmins - By Julie Lellouche

ADVERTISEMENT

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

"*" indicates required fields